pH adjuster sales will rise through 2036, driven by adjuvants at a 27.8% share in 2026 as the leading type segment. The market was valued at USD 1.10 billion in 2025 and is expected to reach USD 1.51 billion by 2036, creating an incremental opportunity of USD 0.37 billion between 2026 and 2036.